| Pharmaceutical active ingredients: |
| Granisetron Hydrochloride |
| Available forms, composition and doses of Granisetron: |
| Solution; Oral; Granisetron Hydrochloride 0.2 mg / ml |
| Granisetron medical category: |
| Human:5-HT3 Receptor AntagonistsAntiemeticsSupportive care therapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A04AA02 - Granisetron |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Cypress Pharmaceutical |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
GFN / DM / PE | Dextromethorphan Hydrobromide; Guaifenesin; Phenylephrine Hydrochloride | Cypress Pharmaceutical |
| GFN / PSE | Guaifenesin; Pseudoephedrine Hydrochloride | Cypress Pharmaceutical |
| GFN Phenylephrine | Guaifenesin; Phenylephrine Hydrochloride | Cypress Pharmaceutical |
| GFN PSE DM | Dextromethorphan Hydrobromide; Guaifenesin; Pseudoephedrine Hydrochloride | Cypress Pharmaceutical |
| GP | Guaifenesin; Pseudoephedrine Hydrochloride | Cypress Pharmaceutical |
| Guaifenesin DAC | Codeine Phosphate; Guaifenesin; Pseudoephedrine Hydrochloride | Cypress Pharmaceutical |
| Guaifenesin PSE | Guaifenesin; Pseudoephedrine Hydrochloride | Cypress Pharmaceutical |
| Hematinic | Ferrous Fumarate; Folic Acid | Cypress Pharmaceutical |
| Hematinic Plus | Ferrous Fumarate; Folic Acid; Multiminerals; Vitamin B | Cypress Pharmaceutical |
| H-Tuss-D | Hydrocodone Tartrate; Pseudoephedrine Hydrochloride | Cypress Pharmaceutical |